RU2312665C2 - Новые быстродействующие фармацевтические композиции, содержащие соединения, активные при сексуальной дисфункции, и порошок какао, и их применение - Google Patents

Новые быстродействующие фармацевтические композиции, содержащие соединения, активные при сексуальной дисфункции, и порошок какао, и их применение Download PDF

Info

Publication number
RU2312665C2
RU2312665C2 RU2005102835/15A RU2005102835A RU2312665C2 RU 2312665 C2 RU2312665 C2 RU 2312665C2 RU 2005102835/15 A RU2005102835/15 A RU 2005102835/15A RU 2005102835 A RU2005102835 A RU 2005102835A RU 2312665 C2 RU2312665 C2 RU 2312665C2
Authority
RU
Russia
Prior art keywords
oil
compound
composition according
sexual dysfunction
cocoa butter
Prior art date
Application number
RU2005102835/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2005102835A (ru
Inventor
Нильс-Олоф ЛИНДБЕРГ (SE)
Нильс-Олоф ЛИНДБЕРГ
Катарина ЛИНДЕЛЛ (SE)
Катарина ЛИНДЕЛЛ
Кристина ТИРЕССОН (SE)
Кристина ТИРЕССОН
Алис С. МАРТИНО (US)
Алис С. МАРТИНО
Original Assignee
Пфайзер Хелт Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Хелт Аб filed Critical Пфайзер Хелт Аб
Publication of RU2005102835A publication Critical patent/RU2005102835A/ru
Application granted granted Critical
Publication of RU2312665C2 publication Critical patent/RU2312665C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Confectionery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2005102835/15A 2002-08-05 2003-06-18 Новые быстродействующие фармацевтические композиции, содержащие соединения, активные при сексуальной дисфункции, и порошок какао, и их применение RU2312665C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0202365A SE0202365D0 (sv) 2002-08-05 2002-08-05 New formulation and use thereof
SE0202365-3 2002-08-05

Publications (2)

Publication Number Publication Date
RU2005102835A RU2005102835A (ru) 2005-08-10
RU2312665C2 true RU2312665C2 (ru) 2007-12-20

Family

ID=20288677

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005102835/15A RU2312665C2 (ru) 2002-08-05 2003-06-18 Новые быстродействующие фармацевтические композиции, содержащие соединения, активные при сексуальной дисфункции, и порошок какао, и их применение

Country Status (15)

Country Link
EP (1) EP1539096A1 (ja)
JP (1) JP2005539008A (ja)
CN (1) CN1674866B (ja)
AR (1) AR040797A1 (ja)
AU (1) AU2003239038B2 (ja)
BR (1) BR0313224A (ja)
CA (1) CA2495527C (ja)
IL (1) IL166031A0 (ja)
MX (1) MXPA05000978A (ja)
NZ (1) NZ537520A (ja)
RU (1) RU2312665C2 (ja)
SE (1) SE0202365D0 (ja)
TW (1) TW200418470A (ja)
WO (1) WO2004012702A1 (ja)
ZA (1) ZA200500051B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
GB0509317D0 (en) * 2005-05-06 2005-06-15 Clarke Anthony Pharmaceutical formulation of apomorphine
DE102010024866A1 (de) * 2010-06-24 2011-12-29 Pharmatech Gmbh Formulierung zur Geschmacksmaskierung
EP3299010B1 (de) 2016-09-21 2022-11-09 LTS Lohmann Therapie-Systeme AG Orale darreichungsform
BR112020017468A2 (pt) 2018-03-01 2020-12-22 Lts Lohmann Therapie-Systeme Ag Forma de dosagem oral com cacau livre de teobromina

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4755180A (en) * 1986-06-16 1988-07-05 Alza Corporation Dosage form comprising solubility regulating member
FR2717387B1 (fr) * 1994-03-17 1996-10-18 Hi Pharmtech Procédé de fabrication de comprimés à croquer à base de troxérutine, de carbonate de calcium, de phosphate de calcium, d'aspartate d'arginine, de glutamate d'arginine d'amoxicilline.
US6121276A (en) 1994-04-22 2000-09-19 Pentech Pharmaceuticals, Inc. Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
ES2105970B1 (es) * 1995-08-02 1998-07-01 S A L V A T Lab Sa Composicion farmaceutica oral de ciprofloxacino, no acuosa, estable y con caracteristicas organolepticas mejoradas.
CA2178021C (en) * 1996-04-19 1999-09-28 Theodore H. Stanley Tobacco substitute
ID21806A (id) * 1997-01-06 1999-07-29 Pfizer Bentuk penakaran farmasi yang secara cepat dilepaskan dan yang menutup rasa
GT199900061A (es) * 1998-05-15 2000-10-14 Pfizer Formulaciones farmaceuticas.
JP2000095710A (ja) * 1998-09-21 2000-04-04 Taisho Pharmaceut Co Ltd カカオ末を配合した経口用固形製剤
JP2000119198A (ja) * 1998-10-16 2000-04-25 Eisai Co Ltd 苦味等の隠蔽されたホスフォジエステラーゼ阻害剤含有経口製剤
US6060094A (en) * 1998-10-30 2000-05-09 Nestec S.A. Method of reducing fat in fat-based coating for confectionery products
SE9803986D0 (sv) 1998-11-23 1998-11-23 Pharmacia & Upjohn Ab New compositions
US6531114B1 (en) * 1999-04-06 2003-03-11 Wm. Wrigley Jr. Company Sildenafil citrate chewing gum formulations and methods of using the same
SI20109A (sl) * 1998-12-16 2000-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Stabilna farmacevtska formulacija
US6291471B1 (en) 1998-12-17 2001-09-18 Abb Holdings, Inc. Use of apomorphine for the treatment of organic erectile dysfunction in males
US6455564B1 (en) * 1999-01-06 2002-09-24 Pharmacia & Upjohn Company Method of treating sexual disturbances
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
JP2003506394A (ja) 1999-08-10 2003-02-18 ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム 視力の保持を容易にするために視神経、脈絡膜、および網膜の血流を増大させるための方法
JP2001114668A (ja) * 1999-10-13 2001-04-24 Meiji Seika Kaisha Ltd チョコレート剤
BR0012822A (pt) 1999-12-30 2004-03-09 Tap Holdings Inc Formulação farmacêutica, e, forma de dosagem em tablete
AU2001273545A1 (en) 2000-07-19 2002-01-30 Lavipharm Laboratories, Inc. Sildenafil citrate solid dispersions having high water solubility
JP2002193839A (ja) * 2000-12-27 2002-07-10 Meiji Seika Kaisha Ltd ココア製剤
JP2004520389A (ja) * 2001-02-08 2004-07-08 ファルマシア・コーポレーション 性的不全の治療のための早期効果発現薬剤
US20020172732A1 (en) * 2001-03-21 2002-11-21 Wies Ter Laak Composition comprising cocoa

Also Published As

Publication number Publication date
RU2005102835A (ru) 2005-08-10
CA2495527C (en) 2008-12-30
AU2003239038B2 (en) 2008-01-03
BR0313224A (pt) 2005-07-05
MXPA05000978A (es) 2005-12-12
JP2005539008A (ja) 2005-12-22
SE0202365D0 (sv) 2002-08-05
CN1674866A (zh) 2005-09-28
AR040797A1 (es) 2005-04-20
EP1539096A1 (en) 2005-06-15
AU2003239038A1 (en) 2004-02-23
IL166031A0 (en) 2006-01-15
ZA200500051B (en) 2006-12-27
WO2004012702A1 (en) 2004-02-12
NZ537520A (en) 2006-11-30
TW200418470A (en) 2004-10-01
CN1674866B (zh) 2012-09-26
CA2495527A1 (en) 2004-02-12

Similar Documents

Publication Publication Date Title
US20100069397A1 (en) Sexual dysfunction compounds
RU2286153C2 (ru) Новые препараты и их использование
US20070122456A1 (en) Nicotine and Cocoa Powder Compositions
JP2011079841A (ja) 活性成分及びカカオ粉末を含む製剤、並びにその使用
KR20150038745A (ko) 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법
JP2002530335A (ja) 急速経粘膜吸収を与えるニコチン含有医薬組成物
AU2002334522A1 (en) New formulations and use thereof
US20100197742A1 (en) New formulations and use thereof
RU2312665C2 (ru) Новые быстродействующие фармацевтические композиции, содержащие соединения, активные при сексуальной дисфункции, и порошок какао, и их применение
CA2556450C (en) Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
CN100548281C (zh) 用于递送催眠药穿过口腔粘膜的组合物及其用法
KR20050047527A (ko) 코코아 분말을 포함하는, 신속하게 발현되는 신규성적-기능장애-화합물-함유 제약 제제 및 그의 용도
US20040191345A1 (en) New formulations and use thereof
MXPA05010314A (es) Nuevas formulaciones y su uso.
KR20160105935A (ko) 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20080619

NF4A Reinstatement of patent

Effective date: 20091210

PC4A Invention patent assignment

Effective date: 20100127

MM4A The patent is invalid due to non-payment of fees

Effective date: 20150619